SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-004804
Filing Date
2020-04-30
Accepted
2020-04-30 16:32:34
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20200331x10q.htm 10-Q 1676741
2 EX-31.1 idra-20200331ex311dddd77.htm EX-31.1 18375
3 EX-31.2 idra-20200331ex3121722ee.htm EX-31.2 18285
4 EX-32.1 idra-20200331ex321b56615.htm EX-32.1 7943
5 EX-32.2 idra-20200331ex3226fe70c.htm EX-32.2 8359
6 GRAPHIC idra20200331x10q001.jpg GRAPHIC 14972
7 GRAPHIC idra20200331x10q002.jpg GRAPHIC 7572
8 GRAPHIC idra20200331x10q003.jpg GRAPHIC 8010
9 GRAPHIC idra20200331x10q004.jpg GRAPHIC 7470
10 GRAPHIC idra20200331x10q005.jpg GRAPHIC 4178
  Complete submission text file 0001558370-20-004804.txt   6997973

Data Files

Seq Description Document Type Size
11 EX-101.INS idra-20200331.xml EX-101.INS 1594864
12 EX-101.SCH idra-20200331.xsd EX-101.SCH 49014
13 EX-101.CAL idra-20200331_cal.xml EX-101.CAL 45516
14 EX-101.DEF idra-20200331_def.xml EX-101.DEF 202717
15 EX-101.LAB idra-20200331_lab.xml EX-101.LAB 405092
16 EX-101.PRE idra-20200331_pre.xml EX-101.PRE 358799
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 20836167
SIC: 2836 Biological Products, (No Diagnostic Substances)